Ownership

Krishna Vaddi - CEO, Director at Prelude Therapeutics Inc

Insider Transactions and Holdings

Entity Type: Individual
Role: CEO, Director
Stock Symbol: PRLD on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Krishna Vaddi - trading volume in the past year for Prelude Therapeutics Inc

	Shares	%	Avg Price	Total $
Buys	+122K	100%	$0.96	+$117K
Sells
Net	+122K	100%		+$117K

Holdings reported by Krishna Vaddi for Prelude Therapeutics Inc

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	1.17M	$1.41M	$1.21	Dec 31, 2024	Direct
Common Stock	424K	$512K	$1.21	Dec 31, 2024	By Trust
Common Stock	143K	$172K	$1.21	Dec 31, 2024	Indirect
Employee Stock Option (right to buy)	425K			Mar 1, 2024	Direct	Common Stock

Transactions reported by Krishna Vaddi for Prelude Therapeutics Inc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.